@ARTICLE{
author={Koehne Claus-Henning|,Bedenne Laurent|,Carrato Alfredo|,Bouche Olivier|,Popov Ivan P|,Gaspa Losa|,Valladares Manuel|,Rougier Phillipe|,Gog Christiane|,Reichardt Peter|,Wils Jacques|,Pignatti Francesco|,Biertz Frank|},
year={2013},
title={A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 study},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={8},
pages={1868-1875},
document_type={Article},
} 

@ARTICLE{
author={Popov Ivan P|,Carrato Alfredo|,Sobrero Alberto|,Vincent Mark|,Kerr David|,Labianca Roberto|,Bianco Angelo Raffaele|,El-Serafi Mostafa|,Bedenne Laurent|,Paillot Bernard|,Mini Enrico|,Sanches Evaristo|,Welch John|,Collette Laurence|,Praet Michel|,Wils Jacques|},
year={2008},
title={Raltitrexed (Tomudex (R)) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)},
journal={EUROPEAN JOURNAL OF CANCER},
volume={44},
number={15},
pages={2204-2211},
document_type={Article},
}